\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:\\ hr\\=108\\,\\ rr\\=20\\ \\ o2\\ sat\\=94\\%\\ on\\ 2l\\ nc\\.\ \(0\)\
\-\ pe\\:\\ chest\\-\\ clear\\ to\\ auscultation\ \(0\)\
\-\ treatment\\:\\ anticoagulation\ \(0\)\
\-\ follow\\-up\\:\\ \\ some\\ advocate\\ a\\ 3\\-4\\ month\\ post\\-treatment\\ v\\/q\\ scan\\ to\\ monitor\\ treatment\\ and\\ basically\\ to\\ re\\-establish\\ a\\ baseline\\ \\(in\\ case\\ of\\ recurrent\\ pe\\)\\.\ \(0\)\
\-\ cxr\\ \\(pa\\/lat\\)\\:\\ \\ unremarkable\ \(0\)\
\-\ ventilation\\/perfusion\\ scintigraphy\\:\ \(0\)\
\-\ ventilation\\:\\ normal\\ \\(\\*homogeneous\\ distribution\\ on\\ wash\\-in\\ phase\\ and\\ equilibrium\\ phase\\ with\\ full\\ lung\\ outline\\ \\*progressive\\,\\ uniform\\ decrease\\ in\\ activity\\ with\\ no\\ activity\\ seen\\ on\\ last\\ wash\\-out\\ image\\)\\ \ \(0\)\
\-\ \\	\ \(2191\)\
\-\ perfusion\\:\\ \\ abnormal\\ \\(\\*large\\ segmental\\ mismatched\\ perfusion\\ defects\\ in\\ rll\\ basal\\ segments\\ and\\ rml\\ lateral\\ segment\\)\ \(0\)\
\-\ \\*high\\ probability\\ v\\/q\\ scan\\:\\ \\(2\\ or\\ more\\ mismatched\\ large\\ perfusion\\ defects\\)\\.\ \(0\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ differential\\ diagnosis\\ \\(v\\/q\\ mismatch\\)\ \(0\)\
\-\ \\*\\*1\\)acute\\ pulmonary\\ embolism\ \(0\)\
\-\ 2\\)chronic\\ pulmonary\\ embolism\\ \\(common\\ cause\\ of\\ false\\+\\,\\ patient\\ had\\ no\\ prior\\ history\\)\ \(0\)\
\-\ 3\\)other\\ embolic\\ causes\ \(0\)\
\-\ \\ \\ \\ \\-septic\\ emboli\\(no\\ signs\\ of\\ infection\\)\ \(1\)\
\-\ \\ \\ \\ \\-fat\\ embolism\\(unlikely\\,\\ seen\\ with\\ long\\ bone\\ fracture\\,\\ no\\ cns\\ sx\\/rash\\/ards\\ picture\\)\ \(0\)\
\-\ 28\\ y\\/o\\ female\\ s\\/p\\ left\\ total\\ hip\\ replacement\\ with\\ tachycardia\\,\\ sob\\.\ \(0\)\
\-\ given\\ the\\ risk\\ factors\\ and\\ clinical\\ picture\\ in\\ this\\ case\\,\\ the\\ patient\\ had\\ a\\ high\\ clinical\\ probability\\ for\\ pe\\ \\(scoring\\ system\\ used\\ in\\ article\\ referenced\\ below\\)\\.\ \(0\)\
\-\ high\\ clinical\\ probability\\ and\\ high\\ probability\\ v\\/q\\ scan\\ together\\ provide\\ high\\ positive\\ predictive\\ value\\ \\(95\\+\\%\\)\\ for\\ pe\\.\\ \\ therefore\\,\\ diagnosis\\ can\\ be\\ confirmed\\ without\\ further\\ work\\-up\\ and\\ the\\ patient\\ can\\ be\\ confidently\\ treated\\ \\(anticoagulation\\)\\.\ \(0\)\
\-\ likewise\\,\\ low\\ clinical\\ probability\\ and\\ normal\\ v\\/q\\ scan\\ have\\ equal\\ confidence\\ in\\ excluding\\ pe\\.\\ \\ \ \(0\)\
\-\ the\\ difficulty\\ is\\ with\\ low\\-probability\\ and\\ indeterminate\\ v\\/q\\ probabilities\\ \\(with\\ intermediate\\ or\\ high\\ clinical\\ probability\\)\\.\\ \\ these\\ patient\\'s\\ need\\ further\\ evaluation\\ \\(ct\\ angio\\-\\-often\\ performed\\ in\\ leiu\\ of\\ v\\/q\\ or\\ pulmonary\\ angiography\\-\\-role\\ is\\ becoming\\ less\\ clear\\)\\ since\\ pe\\ has\\ not\\ been\\ confidently\\ confirmed\\ or\\ excluded\\.\\ \\ \ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ fedulla\\ pf\\,\\ tapson\\ vf\\,\\ the\\ evaluation\\ of\\ suspected\\ pulmonary\\ embolism\\.\\ nejm\\;349\\:1247\\-1256\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ v\\/q\\:\\ 0\\.12513471325397463\ \(0\)\
\-\ probability\\:\\ 0\\.09998281470602144\ \(0\)\
\-\ \\*\\:\\ 0\\.07947201248055843\ \(0\)\
\-\ pe\\:\\ 0\\.0641579612514639\ \(0\)\
\-\ embolism\\:\\ 0\\.05822826512168332\ \(0\)\
\-\ confidently\\:\\ 0\\.04299112053091024\ \(0\)\
\-\ mismatched\\:\\ 0\\.04138843489051035\ \(0\)\
\-\ high\\:\\ 0\\.039084335282620876\ \(0\)\
\-\ clinical\\:\\ 0\\.036619913649944345\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0347708956855162\ \(0\)\
\-\ \\)\\:\\ 0\\.03378869294129857\ \(0\)\
\-\ \\:\\:\\ 0\\.03148397816129986\ \(0\)\
\-\ \\(\\:\\ 0\\.028170095173855287\ \(0\)\
\-\ picture\\:\\ 0\\.027904489884101272\ \(0\)\
\-\ perfusion\\:\\ 0\\.027099023428329084\ \(0\)\
\-\ scan\\:\\ 0\\.02665483521373792\ \(0\)\
\-\ hr\\=108\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ rr\\=20\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ sat\\=94\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ re\\-establish\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ \\-ventilation\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ \\-perfusion\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ false\\+\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ \\-septic\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ \\-fat\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ sx\\/rash\\/ards\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ 95\\+\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ low\\-probability\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ probabilities\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ leiu\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ fedulla\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ tapson\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ 349\\:1247\\-1256\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.02404294570270882\ \(0\)\
\-\ ventilation\\/perfusion\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ wash\\-in\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ equilibrium\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ scoring\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ pf\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ phase\\:\\ 0\\.022394027177547394\ \(0\)\
\-\ defects\\:\\ 0\\.02186723841640526\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.02186723841640526\ \(0\)\
\-\ chest\\-\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ basically\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ mismatch\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ referenced\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ confidence\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ vf\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ advocate\\:\\ 0\\.020694217445255174\ \(0\)\
\-\ post\\-treatment\\:\\ 0\\.020072647664435648\ \(0\)\
\-\ wash\\-out\\:\\ 0\\.020072647664435648\ \(0\)\
\-\ angio\\:\\ 0\\.019564788174758894\ \(0\)\
\-\ 2l\\:\\ 0\\.019135399094460125\ \(0\)\
\-\ excluding\\:\\ 0\\.019135399094460125\ \(0\)\
\-\ likewise\\:\\ 0\\.01876344535455895\ \(0\)\
\-\ outline\\:\\ 0\\.018141875573739422\ \(0\)\
\-\ nejm\\:\\ 0\\.018141875573739422\ \(0\)\
\-\ confirmed\\:\\ 0\\.01790194764950862\ \(0\)\
\-\ activity\\:\\ 0\\.017860984004353975\ \(0\)\
\-\ nc\\:\\ 0\\.01763401608406267\ \(0\)\
\-\ rml\\:\\ 0\\.01763401608406267\ \(0\)\
\-\ predictive\\:\\ 0\\.01763401608406267\ \(0\)\
\-\ clear\\:\\ 0\\.01760181957184761\ \(0\)\
\-\ article\\:\\ 0\\.0172046270037639\ \(0\)\
\-\ indeterminate\\:\\ 0\\.016663802451003573\ \(0\)\
\-\ becoming\\:\\ 0\\.016663802451003573\ \(0\)\
\-\ rll\\:\\ 0\\.01650458681356639\ \(0\)\
\-\ pa\\/lat\\:\\ 0\\.015273854913067672\ \(0\)\
\-\ together\\:\\ 0\\.015273854913067672\ \(0\)\
\-\ further\\:\\ 0\\.01513896457827442\ \(0\)\
\-\ embolic\\:\\ 0\\.014497494460507725\ \(0\)\
\-\ baseline\\:\\ 0\\.01407888108154021\ \(0\)\
\-\ role\\:\\ 0\\.01407888108154021\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.013952244942050636\ \(0\)\
\-\ uniform\\:\\ 0\\.013952244942050636\ \(0\)\
\-\ sob\\:\\ 0\\.01389102236066129\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.013831116496536044\ \(0\)\
\-\ evaluation\\:\\ 0\\.013828628389007286\ \(0\)\
\-\ intermediate\\:\\ 0\\.013715036562272622\ \(0\)\
\-\ o2\\:\\ 0\\.013658761611527443\ \(0\)\
\-\ monitor\\:\\ 0\\.013549511714164542\ \(0\)\
\-\ tachycardia\\:\\ 0\\.013549511714164542\ \(0\)\
\-\ value\\:\\ 0\\.01349645267524896\ \(0\)\
\-\ work\\-up\\:\\ 0\\.013444385452373883\ \(0\)\
\-\ segments\\:\\ 0\\.013393273645498683\ \(0\)\
\-\ provide\\:\\ 0\\.013343082822371444\ \(0\)\
\-\ emboli\\:\\ 0\\.012885414155821928\ \(0\)\
\-\ excluded\\:\\ 0\\.012885414155821928\ \(0\)\
\-\ reference\\:\\ 0\\.012802258269611119\ \(0\)\
\-\ segmental\\:\\ 0\\.01249243755899768\ \(0\)\
\-\ equal\\:\\ 0\\.01245602507552316\ \(0\)\
\-\ cns\\:\\ 0\\.012180688488791593\ \(0\)\
\-\ auscultation\\:\\ 0\\.012115906142930124\ \(0\)\
\-\ angiography\\:\\ 0\\.011960250269965063\ \(0\)\
\-\ need\\:\\ 0\\.011870867778178154\ \(0\)\
\-\ replacement\\:\\ 0\\.011618739623468316\ \(0\)\
\-\ unlikely\\:\\ 0\\.011338680489145539\ \(0\)\
\-\ homogeneous\\:\\ 0\\.011266946516715413\ \(0\)\
\-\ therefore\\:\\ 0\\.01124343991881607\ \(0\)\
\-\ 28\\:\\ 0\\.011220130031154464\ \(0\)\
\-\ or\\:\\ 0\\.01115902784360677\ \(0\)\
\-\ \\%\\:\\ 0\\.011104852553459653\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010931584015489805\ \(0\)\
\-\ decrease\\:\\ 0\\.01089204358085813\ \(0\)\
\-\ basal\\:\\ 0\\.01085107938200104\ \(0\)\
\-\ can\\:\\ 0\\.010797896114033813\ \(0\)\
\-\ distribution\\:\\ 0\\.01071227054147771\ \(0\)\
\-\ factors\\:\\ 0\\.010692993541910651\ \(0\)\
\-\ difficulty\\:\\ 0\\.010598560250334937\ \(0\)\
\-\ case\\:\\ 0\\.010415066478369196\ \(0\)\
\-\ large\\:\\ 0\\.010409707141120222\ \(0\)\
\-\ segment\\:\\ 0\\.010384184091181376\ \(0\)\
\-\ below\\:\\ 0\\.010333072284306178\ \(0\)\
\-\ full\\:\\ 0\\.01028288146117894\ \(0\)\
\-\ had\\:\\ 0\\.010272143839781105\ \(0\)\
\-\ 2\\:\\ 0\\.01025127853209218\ \(0\)\
\-\ total\\:\\ 0\\.010249916398095365\ \(0\)\
\-\ suspected\\:\\ 0\\.010249916398095365\ \(0\)\
\-\ last\\:\\ 0\\.010169171170036169\ \(0\)\
\-\ recurrent\\:\\ 0\\.010044658136838656\ \(0\)\
\-\ cxr\\:\\ 0\\.010044658136838656\ \(0\)\
\-\ s\\/p\\:\\ 0\\.009984428432066607\ \(0\)\
\-\ treatment\\:\\ 0\\.009635749078556473\ \(0\)\
\-\ no\\:\\ 0\\.009587121456309772\ \(0\)\
\-\ patient\\:\\ 0\\.009544199787369225\ \(0\)\
\-\ hip\\:\\ 0\\.009481538640978993\ \(0\)\
\-\ progressive\\:\\ 0\\.009407908398449311\ \(0\)\
\-\ seen\\:\\ 0\\.009407396184221116\ \(0\)\
\-\ vs\\:\\ 0\\.009371810502509187\ \(0\)\
\-\ system\\:\\ 0\\.009371810502509187\ \(0\)\
\-\ causes\\:\\ 0\\.00926624149807747\ \(0\)\
\-\ used\\:\\ 0\\.009131432192055604\ \(0\)\
\-\ since\\:\\ 0\\.008743076940663556\ \(0\)\
\-\ risk\\:\\ 0\\.008621745535819183\ \(0\)\
\-\ signs\\:\\ 0\\.008377091738122714\ \(0\)\
\-\ \\,\\:\\ 0\\.008294737383538054\ \(0\)\
\-\ in\\:\\ 0\\.00821665908351472\ \(0\)\
\-\ long\\:\\ 0\\.008206745155522907\ \(0\)\
\-\ given\\:\\ 0\\.008159928669961956\ \(0\)\
\-\ less\\:\\ 0\\.008061114218169033\ \(0\)\
\-\ cause\\:\\ 0\\.00805365634137038\ \(0\)\
\-\ unremarkable\\:\\ 0\\.007880407851482063\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.007743835630756942\ \(0\)\
\-\ positive\\:\\ 0\\.00772391529327052\ \(0\)\
\-\ often\\:\\ 0\\.007594633839887611\ \(0\)\
\-\ differential\\:\\ 0\\.00755699116811401\ \(0\)\
\-\ normal\\:\\ 0\\.007463022031192763\ \(0\)\
\-\ image\\:\\ 0\\.007435067315592203\ \(0\)\
\-\ be\\:\\ 0\\.007341263082695984\ \(0\)\
\-\ some\\:\\ 0\\.007228212406314092\ \(0\)\
\-\ month\\:\\ 0\\.007140987578831782\ \(0\)\
\-\ treated\\:\\ 0\\.00712493269104139\ \(0\)\
\-\ infection\\:\\ 0\\.006919266223044031\ \(0\)\
\-\ lung\\:\\ 0\\.0068945936496901\ \(0\)\
\-\ abnormal\\:\\ 0\\.006788557772464934\ \(0\)\
\-\ chronic\\:\\ 0\\.0067047064983481895\ \(0\)\
\-\ performed\\:\\ 0\\.006636708443530136\ \(0\)\
\-\ low\\:\\ 0\\.006618852514948188\ \(0\)\
\-\ y\\/o\\:\\ 0\\.00659228142011042\ \(0\)\
\-\ been\\:\\ 0\\.006475751781236744\ \(0\)\
\-\ fracture\\:\\ 0\\.006275973064826682\ \(0\)\
\-\ common\\:\\ 0\\.0062291565792657305\ \(0\)\
\-\ these\\:\\ 0\\.006194553459492591\ \(0\)\
\-\ prior\\:\\ 0\\.006111734741510761\ \(0\)\
\-\ on\\:\\ 0\\.006049228515588536\ \(0\)\
\-\ more\\:\\ 0\\.005953137351844474\ \(0\)\
\-\ bone\\:\\ 0\\.005914859836935571\ \(0\)\
\-\ acute\\:\\ 0\\.005877101195282716\ \(0\)\
\-\ 1\\:\\ 0\\.005663861749191384\ \(0\)\
\-\ \\;\\:\\ 0\\.005641841750564328\ \(0\)\
\-\ without\\:\\ 0\\.005604493499604903\ \(0\)\
\-\ 3\\:\\ 0\\.005573747985254985\ \(0\)\
\-\ other\\:\\ 0\\.0054864583529316115\ \(0\)\
\-\ \\'s\\:\\ 0\\.005248040719685362\ \(0\)\
\-\ have\\:\\ 0\\.005154423616615855\ \(0\)\
\-\ lateral\\:\\ 0\\.005143922132658915\ \(0\)\
\-\ female\\:\\ 0\\.0048934826502725175\ \(0\)\
\-\ has\\:\\ 0\\.004469916352351749\ \(0\)\
\-\ for\\:\\ 0\\.004061883836449666\ \(0\)\
\-\ and\\:\\ 0\\.00401134274612186\ \(0\)\
\-\ to\\:\\ 0\\.0035688142766823368\ \(0\)\
\-\ not\\:\\ 0\\.0034396063279719647\ \(0\)\
\-\ ct\\:\\ 0\\.00332953663897505\ \(0\)\
\-\ a\\:\\ 0\\.003314204472021738\ \(0\)\
\-\ history\\:\\ 0\\.003287505676064299\ \(0\)\
\-\ is\\:\\ 0\\.003132539155346661\ \(0\)\
\-\ this\\:\\ 0\\.002677262432629897\ \(0\)\
\-\ left\\:\\ 0\\.0026632458754120188\ \(0\)\
\-\ with\\:\\ 0\\.0019555015502488535\ \(0\)\
\-\ the\\:\\ 0\\.0019254775028360138\ \(0\)\
\-\ of\\:\\ 0\\.0016226156099998388\ \(0\)\
\-\ \\.\\:\\ 0\\.0011866140199670065\ \(0\)\
